In these studies, homozygotes of factor V 1691A allele and prothrombin 20210A allele were rarely detected in either the patient or the control groups, so the heterozygotes and homozygotes of each thrombophilia gene mutation were considered together. This evidence concerns the gene F2 and Rare hereditary thrombophilia.